During the past decade, Desert Endocrinology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Desert Endocrinology" are "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type II" (1 trials). Many other conditions were trialed in "Desert Endocrinology" in a lesser frequency.

Most popular intervention types in "Desert Endocrinology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin aspart" (2 trials), "Insulin glargine" (2 trials), "Insulin glulisine" (2 trials), "Insulin lispro" (2 trials) and "Recombinant human hyaluronidase PH20" (1 trials). Other intervention names were less common.

The vast majority of trials in "Desert Endocrinology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Desert Endocrinology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Desert Endocrinology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Desert Endocrinology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Desert Endocrinology has several departments that took part in Clinical trials: "Desert Endocrinology Clinical Research Center" - 10 trials